Dermapharm Holding SE (DMP)
FSX
Closed
Oct 5, 2026
Day's Range
37.3052 wk Range
32.30Overview - DMP - Dermapharm Holding SE
Key Statistics
Valuation
Enterprise Value
2.87B
P/E (Trailing)
‪13.86‬
P/E (Forward)
‪12.94‬
PEG Ratio
‪0.67‬
Price / Sales (TTM)
‪1.60‬
Price / Book
‪3.53‬
EV / EBITDA
‪9.27‬
Profitability
Gross Margin
‪69.30%‬
Profit Margin
‪12.39%‬
Operating Margin
‪15.86%‬
Return on Assets
‪7.11%‬
Return on Equity
‪25.56%‬
Ownership
Shares Outstanding
49.54M
Float
6.46M
Held by Insiders
‪89.29%‬
Held by Institutions
‪7.97%‬
Price stats
Beta
‪0.84‬
50-Day Avg
‪41.59‬
200-Day Avg
‪41.80‬
Dividends
Payout Ratio
‪31.77%‬
Frequency
Annual
Analyst Consensus
6 analysts
Market Cap - DMP - Dermapharm Holding SE
Peers - DMP - Dermapharm Holding SE
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on FSX.
Profile Summary - DMP - Dermapharm Holding SE
About
Dermapharm Holding SE is a leading manufacturer of branded pharmaceuticals and other healthcare products, founded in 1991 by Wilhelm Beier and headquartered in Grünwald near Munich, Germany. The company operates an integrated business model encompassing in-house product development, production, quality management, and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
